封面
市场调查报告书
商品编码
1703373

男性人工尿道括约肌市场-全球产业规模、份额、趋势、机会与预测,按类型(带球囊储液器的澳洲尿道括约肌、带弹簧的澳洲尿道括约肌)、按最终用户、按地区和竞争情况细分,2020 年至 2030 年预测

Male Artificial Urinary Sphincter Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (AUS with a balloon reservoir, AUS with a spring ), By End-user, By Region, & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球男性人工尿道括约肌市场价值为 2.5325 亿美元,预计在预测期内将呈现强劲增长,到 2030 年年复合成长率(CAGR) 为 5.35%。尿失禁 (UI) 是一项重大的医学挑战,具有深远的经济和社会影响。男性尿失禁发生率的上升与泌尿系统疾病的增加密切相关,例如前列腺炎引起的尿失禁、手术干预导致的神经和肌肉损伤、感染以及其他损害正常膀胱功能的因素。

市场概览
预测期 2026-2030
2024年市场规模 2.5325亿美元
2030年市场规模 3.4703亿美元
2025-2030 年复合年增长率 5.35%
成长最快的领域 附球囊储液器的 AUS(3 组分)
最大的市场 欧洲

一个常见的潜在原因是良性前列腺增生(BPH)或前列腺增大,随着年龄的增长而变得更加普遍。此外,摄护腺炎(摄护腺的发炎)也会引发尿失禁。手术,特别是涉及骨盆区域的手术,可能会导致神经或肌肉损伤,进一步导致男性失禁。

关键市场驱动因素

人口老化日益加剧

主要市场挑战

治疗费用高昂

主要市场趋势

采用微创手术

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:全球男性人工尿道括约肌市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依类型(带球囊储液器的 AUS(3 组分)、带弹簧的 AUS(2 组分))
    • 按最终使用者(医院、诊所和其他医疗中心、学术和研究中心)
    • 按地区
    • 按公司分类(2024)
  • 产品市场图

第六章:北美男性人工尿道括约肌市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章:欧洲男性人工尿道括约肌市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙

第八章:亚太男性人工尿道括约肌市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国

第九章:南美男性人工尿道括约肌市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章:中东与非洲男性人工尿道括约肌市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 科威特

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章:竞争格局

  • Boston Scientific Corporation
  • Zephyr Surgical Implants
  • Affluent Medical
  • UroMems
  • Rigicon
  • ProMinent GmbH
  • Coloplast A/S
  • Medtronic Plc
  • Stryker

第 15 章:策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 16618

The global male artificial urinary sphincter market was valued at USD 253.25 million in 2024 and is expected to exhibit robust growth during the forecast period, registering a compound annual growth rate (CAGR) of 5.35% through 2030. Urinary incontinence (UI) represents a significant medical challenge with far-reaching economic and societal consequences. The rising incidence of male urinary incontinence is closely linked to an increase in urological disorders such as prostatitis-induced incontinence, nerve and muscle damage resulting from surgical interventions, infections, and other factors that impair normal bladder function.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 253.25 Million
Market Size 2030USD 347.03 Million
CAGR 2025-20305.35%
Fastest Growing SegmentAUS with a balloon reservoir (3-component)
Largest MarketEurope

A common underlying cause is benign prostatic hyperplasia (BPH), or prostate gland enlargement, which becomes more prevalent with advancing age. Additionally, prostatitis-an inflammation of the prostate-can also trigger incontinence. Surgical procedures, particularly those involving the pelvic region, may lead to nerve or muscle damage, further contributing to incontinence in men.

Key Market Drivers

Growing Aging Population

The global healthcare sector is undergoing a profound transformation, driven by a steady rise in the aging population. Increased life expectancy has led to a surge in age-related health conditions, with urinary incontinence emerging as a major concern. In 2017, the global population aged 60 and above reached approximately 962 million-more than double the 382 million recorded in 1980. According to long-term projections, this number is expected to exceed 2.1 billion by 2050.

This demographic shift is expanding the patient base for conditions such as urinary incontinence. Data shows that around 15% of older adults living independently and nearly 50% of those in long-term care facilities suffer from significant forms of UI. The aging process leads to physiological changes-including weakened pelvic muscles and hormonal imbalances-that heighten the risk of incontinence. Moreover, age-related conditions like BPH and prostatitis are among the leading contributors.

The growing demand for enhanced quality of life among the elderly population is a key growth driver for the male artificial urinary sphincter market. Urinary incontinence can have a substantial impact on an individual's day-to-day life, often resulting in social withdrawal, emotional distress, and diminished independence. As a result, healthcare professionals are increasingly recommending artificial urinary sphincters to restore continence and improve patient well-being.

Concurrently, technological advancements have significantly enhanced the functionality, comfort, and reliability of modern male artificial urinary sphincters. These innovations offer improved control, reduced risk of complications, and enhanced ease of use-making them a more attractive solution for older patients aiming to maintain independence and dignity.

Rising healthcare expenditure, both from governments and private providers, is further fueling the adoption of advanced medical technologies. The increasing focus on senior care has led to expanded investments in healthcare infrastructure, including devices like artificial urinary sphincters, which are integral to improving patient outcomes and supporting aging populatios.

Key Market Challenges

High Cost of Treatment

A major barrier to wider market adoption is the high cost associated with male artificial urinary sphincter implantation. The overall expense, encompassing both the surgical procedure and the device itself, can be considerable. This financial burden is particularly challenging for patients lacking adequate insurance coverage or access to affordable healthcare services, thereby limiting market penetration in some regions.

Key Market Trends

Adoption of Minimally Invasive Procedures

One of the emerging trends in the market is the increasing use of minimally invasive surgical techniques for the implantation of artificial urinary sphincters. These procedures, which involve smaller incisions and minimal tissue disruption, offer several advantages, including shorter recovery times, reduced post-operative discomfort, and lower risk of complications. As these approaches continue to evolve and become more accessible, they are expected to become the standard method for device implantation, further supporting market growth.

Key Market Players

  • Boston Scientific Corporation
  • Zephyr Surgical Implants
  • Affluent Medical
  • UroMems
  • Rigicon
  • ProMinent GmbH
  • Coloplast A/S
  • Medtronic Plc
  • Stryker

Report Scope:

In this report, the Global Male Artificial Urinary Sphincter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Male Artificial Urinary Sphincter Market, By Type:

  • AUS with a balloon reservoir (3-component)
  • AUS with a spring (2-component)

Male Artificial Urinary Sphincter Market, By End-user:

  • Hospitals
  • Clinics & Other Healthcare Centers
  • Academic & Research Centers

Male Artificial Urinary Sphincter Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Male Artificial Urinary Sphincter Market.

Available Customizations:

Global Male Artificial Urinary Sphincter market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Male Artificial Urinary Sphincter Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component))
    • 5.2.2. By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map

6. North America Male Artificial Urinary Sphincter Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End-user
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Male Artificial Urinary Sphincter Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End-user
    • 6.3.2. Canada Male Artificial Urinary Sphincter Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End-user
    • 6.3.3. Mexico Male Artificial Urinary Sphincter Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End-user

7. Europe Male Artificial Urinary Sphincter Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End-user
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Male Artificial Urinary Sphincter Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End-user
    • 7.3.2. United Kingdom Male Artificial Urinary Sphincter Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End-user
    • 7.3.3. France Male Artificial Urinary Sphincter Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End-user
    • 7.3.4. Italy Male Artificial Urinary Sphincter Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End-user
    • 7.3.5. Spain Male Artificial Urinary Sphincter Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End-user

8. Asia-Pacific Male Artificial Urinary Sphincter Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End-user
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Male Artificial Urinary Sphincter Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End-user
    • 8.3.2. Japan Male Artificial Urinary Sphincter Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End-user
    • 8.3.3. India Male Artificial Urinary Sphincter Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End-user
    • 8.3.4. Australia Male Artificial Urinary Sphincter Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End-user
    • 8.3.5. South Korea Male Artificial Urinary Sphincter Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End-user

9. South America Male Artificial Urinary Sphincter Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End-user
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Male Artificial Urinary Sphincter Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End-user
    • 9.3.2. Argentina Male Artificial Urinary Sphincter Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End-user
    • 9.3.3. Colombia Male Artificial Urinary Sphincter Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End-user

10. Middle East and Africa Male Artificial Urinary Sphincter Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End-user
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Male Artificial Urinary Sphincter Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End-user
    • 10.3.2. Saudi Arabia Male Artificial Urinary Sphincter Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End-user
    • 10.3.3. UAE Male Artificial Urinary Sphincter Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End-user
    • 10.3.4. Kuwait Male Artificial Urinary Sphincter Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By End-user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Boston Scientific Corporation
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Zephyr Surgical Implants
  • 14.3. Affluent Medical
  • 14.4. UroMems
  • 14.5. Rigicon
  • 14.6. ProMinent GmbH
  • 14.7. Coloplast A/S
  • 14.8. Medtronic Plc
  • 14.9. Stryker

15. Strategic Recommendations

16. About Us & Disclaimer